CENTRAL PONTINE MYELINOLYSIS

CENTRAL PONTINE MYELINOLYSIS was reported 72 times

CENTRAL PONTINE MYELINOLYSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Typical Antipsychotic [EPC] 2 0.0001
1 Calcineurin Inhibitor Immunosuppressant [EPC] 9 0.0001
2 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
3 Protease Inhibitor [EPC] 2 0.0000
4 Alkylating Drug [EPC] 10 0.0000
5 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 4 0.0000
6 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 4 0.0000
7 Cytochrome P450 3A Inhibitor [EPC] 2 0.0000
8 Nitroimidazole Antimicrobial [EPC] 2 0.0000
9 Nucleoside Analog Antiviral [EPC] 2 0.0000
10 Thiazide-like Diuretic [EPC] 1 0.0000
11 Thiazide Diuretic [EPC] 4 0.0000
12 Macrolide Antimicrobial [EPC] 1 0.0000
13 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0000
14 Fluoroquinolone Antibacterial [EPC] 2 0.0000
15 Mood Stabilizer [EPC] 3 0.0000
16 Anti-epileptic Agent [EPC] 3 0.0000
17 Atypical Antipsychotic [EPC] 6 0.0000
18 beta-Adrenergic Blocker [EPC] 4 0.0000
19 Azole Antifungal [EPC] 2 0.0000
20 Benzodiazepine [EPC] 8 0.0000
21 5-alpha Reductase Inhibitor [EPC] 1 0.0000
22 Antirheumatic Agent [EPC] 1 0.0000
23 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
24 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
25 Folate Analog Metabolic Inhibitor [EPC] 3 0.0000
26 Osmotic Laxative [EPC] 2 0.0000
27 Corticosteroid [EPC] 8 0.0000
28 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
29 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
30 Proton Pump Inhibitor [EPC] 3 0.0000
31 Insulin Analog [EPC] 2 0.0000
32 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
33 Nonsteroidal Anti-inflammatory Drug [EPC] 4 0.0000
34 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
35 Loop Diuretic [EPC] 1 0.0000
36 Kinase Inhibitor [EPC] 1 0.0000
37 Platelet Aggregation Inhibitor [EPC] 1 0.0000
38 Tumor Necrosis Factor Blocker [EPC] 1 0.0000